The American hookworm, *Necator americanus*, has traveled from a feared disease vector to a controversial candidate for treating chronic illnesses.. Over the past 118 years, researchers have shifted from mass deworming campaigns to controlled infections aimed at modulating the immune system.. Radiolab’s latest episode revisits this tangled history and highlights new studies that suggest the parasite could alleviate conditions such as asthma and multiple sclerosis.

118‑Year Evolution of *Necator americanus* from Epidemic to Experiment

According to the Radiolab episode, the hookworm first entered the public eye in the early 1900s when it was linked to severe anemia and economic decline in the American South. by the 1920s, public health officials launched large‑scale deworming drives that dramatically reduced infection rates. The program marked the beginning of a century‑long effort to eradicate the parasite, a goal that seemed unequivocal until recent immunological research hinted at a paradoxical benefit.

In the 1970s, a handful of physicians began a “desperate DIY” approach, deliberately infecting patients with low‑dose hookworms to suppress overactive immune responses. The practice was anecdotal and largely undocumented, but it set the stage for contemporary clinical trials that now follow rigorous protocols.

New Clinical Trials Target Asthma and Multiple Sclerosis with Hookworm Therapy

The episode cites recent research led by Dr. Molly Webster, who reported that controlled hookworm infection reduced airway inflammation in a small cohort of asthma sufferers. Participants received a measured dose of *N. americanus* larvae and were monitored for changes in cytokine profiles, with preliminary results showing a modest but statistically significant improvement.

Another study referenced in the broadcast explored the worm’s impact on multiple sclerosis (MS). Researchers observed a decline in relapse frequency among patients who maintained a low‑level infection for six months. While the sample size was limited, the findings echo earlier animal studies that suggested helminths could recalibrate the immune system’s balance between Th1 and Th2 pathways.

Ethical Quandaries: Is It Acceptable to Re‑Introduce a Parasite?

Radiolab’s producers note that the ethical debate is as intense as the scientific one. Critics argue that deliberately infecting humans with a pathogen, even in a controlled setting, contravenes the precautionary principle and could lead to unintended health complications. Proponents counter that the potential to curb rising autoimmune disease rates—conditions that have surged in post‑sanitation societies—justifies carefully supervised trials.

Funding sources add another layer of complexity. The episode acknowledges support from the Simons Foundation and the John Templeton Foundation, both of which have histories of backing unconventional biomedical research. transparency about sponsor influence remains a point of contention among bioethicists.

Who Is Still Missing from the Conversation?

One glaring omission in the report is the perspective of communities still burdened by endemic hookworm infections. While the focus is on therapeutic applications in affluent settings, millions in tropical regions continue to suffer from the parasite’s classic symptoms. Their voices are absent from the discussion about “harnessing” the worm for health benefits.

Additionally, the episode does not address long‑term safety data beyond the trial periods. Questions remain about whether chronic low‑grade infection could predispose individuals to other conditions, such as gastrointestinal cancers, a risk hinted at in older epidemiological studies.

Historical Echo: Past Attempts to Use Parasites as Medicine

The conecpt of “therapeutic parasites” is not new. In the 1910s, physicians experimented with leeches and maggots for wound healing, practices that have since been refined into modern medical devices.. The current hookworm revival mirrors those early efforts, suggesting a cyclical pattern where discarded folk remedies re‑emerge under scientific scrutiny.

As Radiolab points out, the story of *N. americanus* reflects broader shifts in how humanity perceives the microbial world—from enemies to potential allies. whether the worm will transition from a historical scourge to a mainstream treatment remains uncertain, but the dialogue it has sparked is reshaping research priorities in immunology.